Articles by The Wall Street Analyzer

About The Wall Street Analyzer
The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.
No Picture
News Feed

POSITIVE DATA PRESENTED ON PIERIS PHARMACEUTICALS’ INHALED ASTHMA PROGRAM AT ERS AND COMPANY STRENGTHENS MANAGEMENT TEAM

September 30, 2015 The Wall Street Analyzer Comments Off on POSITIVE DATA PRESENTED ON PIERIS PHARMACEUTICALS’ INHALED ASTHMA PROGRAM AT ERS AND COMPANY STRENGTHENS MANAGEMENT TEAM

PRECLINICAL DATA ON THE IL-4 RECEPTOR ANTAGONIST PRS-060 PRESENTED AT THE EUROPEAN RESPIRATORY SOCIETY CONFERENCE; MARY FITZGERALD, PH.D., TO LEAD PIERIS RESPIRATORY DRUG DEVELOPMENT PROGRAM […]